Nomogram predicting overall survival of stage IIIB non ‐small‐cell lung cancer patients based on the SEER database

ConclusionsWe developed the first validated nomogram to estimate the OS of patients with stage IIIB NSCLC. The nomogram was based on nine prognostic factors and provided an individualized risk estimate of 3-year and 5-year OS survival in patients with stage IIIB NSCLC.

Source: The Clinical Respiratory Journal - July 20, 2023 Category: Respiratory Medicine Authors: Ziye Li, Pingfan Shi, Chenge Qin, Wen Zhang, Shumeng Lin, Tiansheng Zheng, Ming Li, Lihong Fan Tags: ORIGINAL ARTICLE Source Type: research